title: Acetaminophen Increases Aldosterone Secretion While Suppressing Cortisol and Androgens: A Possible Link to Increased Risk of Hypertension.
abstract: Acetaminophen (paracetamol) is a widely used analgesic and antipyretic drug. Potential side effects are of public health concern, and liver toxicity from acute overdose is well known. More recently, a regular use of acetaminophen has been associated with an increased risk of hypertension.
  
  
  
  We investigated effects of acetaminophen on steroidogenesis as a possible mechanism for the hypertensive action by using the human adrenocortical cell line, H295R. Cells were treated with 0.1, 0.5, and 1mM of acetaminophen for 24 hours, and secretion of steroids and gene expression of key steps in the steroidogenesis were investigated.
  
  
  
  Progesterone and aldosterone secretion were increased dose dependently, while secretion of 17α-OH-progesterone and cortisol as well as dehydroepiandrosterone and androstenedione was decreased. CYP17α-hydroxylase activity, assessed by the ratio 17α-OH-progesterone/progesterone, and CYP17-lyase activity, assessed by the ratio androstenedione/17α-OH-progesterone, were both dose-dependently decreased by acetaminophen. No effects were revealed on cell viability. Treatment of cells with 0.5mM of acetaminophen did not cause any effects on the expression of 10 genes in the steroidogenic pathways.
  
  
  
  The pattern of steroid secretion caused by acetaminophen can be explained by inhibition of CYP17A1 enzyme activity. A decreased secretion of glucocorticoids and androgens, as demonstrated by acetaminophen, would, in an in vivo situation, induce adrenocorticotropic hormone release via negative feedback in the hypothalamic-pituitary-adrenal axis and result in an upregulation of aldosterone secretion. Our results suggest a novel possible mechanism for acetaminophen-induced hypertension, which needs to be further elucidated in clinical investigations.
authors.affiliation: Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden; Agneta.Oskarsson@slu.se.
authors.forename: Agneta
authors.initials: A
authors.lastname: Oskarsson
authors.affiliation: Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
authors.forename: Erik
authors.initials: E
authors.lastname: Ullerås
authors.affiliation: Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden;
authors.forename: Åsa
authors.initials: Å
authors.lastname: Ohlsson Andersson
mesh_terms: D000082:Acetaminophen / Q000009:adverse effects*; D000305:Adrenal Cortex Hormones / Q000378:metabolism*; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects*; D045744:Cell Line, Tumor; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D013254:Steroid 17-alpha-Hydroxylase / Q000378:metabolism
chemical_list: D000305:Adrenal Cortex Hormones; D018712:Analgesics, Non-Narcotic; D000082:Acetaminophen; D013254:Steroid 17-alpha-Hydroxylase
keywords: CYP17; H295R.; acetaminophen; aldosterone; blood pressure; hypertension; paracetamol; steroidogenesis